Skip to main content

Biolife Solutions Inc

BLFS
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000834365

No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Biolife Solutions Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Biolife Solutions Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Biolife Solutions Inc
NameTitleLast reported holdingLast filingFilings, past year
Berard ToddChief Marketing Officer161,823Sep 22, 202613
Mathew Aby J.EVP & Chief Scientific Officer387,269Sep 22, 202613
Werner SeanChief Technology Officer47,135Sep 22, 20268
De Greef RoderickPresident and CEO728,196Sep 22, 20266
Wichterman TroyChief Financial Officer211,286Sep 22, 202614
Casdin Partners GP, LLC10% Owner4,757,165IndirectMay 21, 20262
Casdin Capital, LLC10% Owner4,757,165IndirectMay 21, 20262
Casdin Eli10% Owner4,757,165IndirectMay 21, 20262
Casdin Partners Master Fund, L.P.10% Owner4,757,165IndirectMay 21, 20262
Foster Karen A.Chief Quality and Operations108,758Mar 31, 20269
Aebersold SarahChief Human Resources Officer92,429Mar 23, 20267
Goswami JoydeepDirector53,156Feb 26, 20263
Ellingson RachelDirector57,995Feb 26, 20261
Hunt AnthonyDirector15,046Feb 26, 20261
Moore Timothy L.Director44,943Feb 26, 20261
Coste CatherineDirector13,871Feb 26, 20261
DuRoss AmyDirector26,857Feb 26, 20264
Richardson GarrieChief Revenue Officer114,773Sep 18, 20240
Schick Joseph CDirector43,953Mar 12, 20240
Phillips GeraintSVP, Global Operations65,998Mar 12, 20240
Rice MichaelOther: Former CEO and Director347,085Nov 1, 20230
Schulz MarcusChief Revenue Officer42,097Aug 29, 20230
Hinson Andrew GDirector17,675Aug 18, 20210
Cohen Raymond WDirector27,763Jul 14, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 23, 2024 (view filing)Apr 185 daysLateMathew Aby J.EVP & Chief Scientific OfficerSSale−584$15.31−$8.94K−0.2%319.1K after10b5-1
Apr 23, 2024 (view filing)Apr 185 daysLateBerard ToddChief Marketing OfficerSSale−332$15.31−$5.08K−0.3%129.3K after10b5-1
Apr 23, 2024 (view filing)Apr 185 daysLateWichterman TroyChief Financial OfficerSSale−956$15.31−$14.6K−0.7%126.7K after10b5-1
Apr 18, 2024 (view filing)Apr 153 daysLateBerard ToddChief Marketing OfficerSSale−10.0K$15.67−$156.7K−7.2%129.6K after10b5-1
Apr 3, 2024 (view filing)Apr 12 daysAebersold SarahChief Human Resources OfficerSSale−4.00K$17.65−$70.6K−5.7%65.8K after10b5-1
Mar 29, 2024 (view filing)Mar 272 daysMathew Aby J.EVP & Chief Scientific OfficerSSale−454$17.99−$8.17K−0.1%319.7K after10b5-1
Mar 29, 2024 (view filing)Mar 272 daysBerard ToddChief Marketing OfficerSSale−515$17.99−$9.26K−0.4%139.6K after10b5-1
Mar 29, 2024 (view filing)Mar 272 daysFoster Karen A.Chief Quality and OperationsSSale−395$17.99−$7.11K−0.2%159.1K after10b5-1
Mar 25, 2024 (view filing)Mar 214 daysWichterman TroyChief Financial OfficerSSale−520$17.83−$9.27K−0.4%127.6K after10b5-1
Mar 13, 2024 (view filing)Mar 12-131 dayDuRoss AmyDirectorSSale−11.2K$16.92−$189.5K−27.6%29.4K after2 lots
Mar 12, 2024 (view filing)Mar 11-121 dayBerard ToddChief Marketing OfficerSSale−7.51K$16.64−$125.0K−5.1%140.2K after2 lots10b5-1
Mar 12, 2024 (view filing)Mar 11-121 dayMathew Aby J.EVP & Chief Scientific OfficerSSale−6.83K$16.64−$113.7K−2.1%320.1K after2 lots10b5-1
Mar 12, 2024 (view filing)Mar 11-121 dayPhillips GeraintSVP, Global OperationsSSale−3.80K$16.64−$63.3K−5.4%66.0K after2 lots10b5-1
Mar 12, 2024 (view filing)Mar 12Same dayDe Greef RoderickPresident and CEOSSale−7.25K$16.60−$120.3K−1.5%461.9K after10b5-1
Mar 12, 2024 (view filing)Mar 11-121 dayWichterman TroyChief Financial OfficerSSale−7.61K$16.64−$126.6K−5.6%128.1K after2 lots10b5-1
Mar 12, 2024 (view filing)Mar 11-121 dayFoster Karen A.Chief Quality and OperationsSSale−5.50K$16.65−$91.5K−3.3%159.5K after2 lots10b5-1
Mar 12, 2024 (view filing)Mar 11-121 dayAebersold SarahChief Human Resources OfficerSSale−4.63K$16.65−$77.1K−6.2%69.8K after2 lots10b5-1
Feb 23, 2024 (view filing)Feb 212 daysAebersold SarahChief Human Resources OfficerSSale−58$17.35−$1.01K−0.1%41.8K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysWichterman TroyChief Financial OfficerSSale−97$17.35−$1.68K−0.1%64.8K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysPhillips GeraintSVP, Global OperationsSSale−131$17.35−$2.27K−0.2%58.1K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysBerard ToddChief Marketing OfficerSSale−111$17.35−$1.93K−0.1%115.7K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysMathew Aby J.EVP & Chief Scientific OfficerSSale−101$17.35−$1.75K0.0%275.2K after10b5-1
Feb 23, 2024 (view filing)Feb 212 daysFoster Karen A.Chief Quality and OperationsSSale−87$17.35−$1.51K−0.1%123.9K after10b5-1
Jan 25, 2024 (view filing)Jan 232 daysAebersold SarahChief Human Resources OfficerSSale−336$17.11−$5.75K−0.8%41.9K after10b5-1
Jan 23, 2024 (view filing)Jan 194 daysFoster Karen A.Chief Quality and OperationsSSale−1.20K$16.76−$20.1K−1.0%124.0K after10b5-1
Jan 23, 2024 (view filing)Jan 194 daysPhillips GeraintSVP, Global OperationsSSale−1.78K$16.76−$29.8K−3.0%58.3K after10b5-1
Jan 23, 2024 (view filing)Jan 194 daysMathew Aby J.EVP & Chief Scientific OfficerSSale−1.45K$16.76−$24.3K−0.5%275.3K after10b5-1
Jan 23, 2024 (view filing)Jan 194 daysDe Greef RoderickPresident and CEOSSale−2.64K$16.76−$44.3K−0.6%439.9K after10b5-1
Jan 23, 2024 (view filing)Jan 194 daysWichterman TroyChief Financial OfficerSSale−2.42K$16.76−$40.5K−3.6%64.9K after10b5-1
Jan 23, 2024 (view filing)Jan 194 daysAebersold SarahChief Human Resources OfficerSSale−862$16.76−$14.4K−2.0%42.2K after10b5-1
Jan 23, 2024 (view filing)Jan 194 daysBerard ToddChief Marketing OfficerSSale−1.23K$16.76−$20.6K−1.1%115.8K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysFoster Karen A.Chief Quality and OperationsSSale−601$16.75−$10.1K−0.5%125.2K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysBerard ToddChief Marketing OfficerSSale−491$16.75−$8.22K−0.4%117.0K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysMathew Aby J.EVP & Chief Scientific OfficerSSale−697$16.75−$11.7K−0.3%276.8K after10b5-1
Dec 28, 2023 (view filing)Dec 226 daysLateWichterman TroyChief Financial OfficerSSale−314$16.79−$5.27K−0.5%67.3K after10b5-1
Dec 4, 2023 (view filing)Dec 13 daysFoster Karen A.Chief Quality OfficerSSale−466$12.37−$5.76K−0.4%125.3K after10b5-1
Dec 4, 2023 (view filing)Dec 13 daysAebersold SarahChief Human Resources OfficerSSale−394$12.37−$4.87K−0.9%43.1K after10b5-1
Dec 4, 2023 (view filing)Dec 13 daysMathew Aby J.EVP & Chief Scientific OfficerSSale−591$12.37−$7.31K−0.2%276.0K after10b5-1
Dec 4, 2023 (view filing)Dec 13 daysPhillips GeraintSVP, Global OperationsSSale−303$12.37−$3.75K−0.5%59.6K after10b5-1
Dec 4, 2023 (view filing)Dec 13 daysBerard ToddChief Marketing OfficerSSale−394$12.37−$4.87K−0.3%117.5K after10b5-1
Dec 4, 2023 (view filing)Dec 13 daysWichterman TroyChief Financial OfficerSSale−666$12.37−$8.24K−1.0%67.1K after10b5-1
Nov 15, 2023 (view filing)Nov 132 daysFoster Karen A.Chief Quality OfficerSSale−114$10.77−$1.23K−0.1%125.5K after10b5-1
Nov 15, 2023 (view filing)Nov 132 daysAebersold SarahChief Human Resources OfficerSSale−76$10.77−$818.52−0.2%43.5K after10b5-1
Nov 15, 2023 (view filing)Nov 132 daysBerard ToddChief Marketing OfficerSSale−98$10.77−$1.06K−0.1%117.9K after10b5-1
Nov 15, 2023 (view filing)Nov 132 daysPhillips GeraintSVP, Global OperationsSSale−111$10.66−$1.18K−0.2%59.7K after10b5-1
Nov 15, 2023 (view filing)Nov 132 daysMathew Aby J.EVP & Chief Scientific OfficerSSale−132$10.77−$1.42K0.0%275.7K after10b5-1
Nov 15, 2023 (view filing)Nov 132 daysWichterman TroyChief Financial OfficerSSale−97$10.66−$1.03K−0.1%67.5K after10b5-1
Nov 1, 2023 (view filing)Oct 302 daysRice MichaelOther: Former CEO and DirectorSSale−72.6K$9.13−$662.9K−17.3%347.1K after10b5-1
Oct 23, 2023 (view filing)5:42 PM ETOct 194 daysCasdin Partners GP, LLC and 3 others10% OwnerPPurchaseCommon Stock, par value $.001 per share+927.2K$11.19+$10.4M+12.2%8.56M after
Oct 2, 2023 (view filing)Sep 284 daysFoster Karen A.Chief Quality OfficerSSale−568$14.16−$8.04K−0.5%124.8K after10b5-1